Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 168

1.

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Li AA, Ahmed A, Kim D.

Gut Liver. 2019 Jun 17. doi: 10.5009/gnl19069. [Epub ahead of print]

2.

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.

Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A.

Sci Rep. 2019 Jun 5;9(1):8312. doi: 10.1038/s41598-019-44814-y.

3.

Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers.

Gadiparthi C, Yoo ER, Are VS, Charilaou P, Kim D, Cholankeril G, Pitchumoni C, Ahmed A.

Ann Hepatol. 2019 May 21. pii: S1665-2681(19)30343-6. doi: 10.1016/j.aohep.2019.04.014. [Epub ahead of print]

4.

Economic burden and healthcare utilization in nonalcoholic fatty liver disease.

Yoo ER, Ahmed A, Kim D.

Hepatobiliary Surg Nutr. 2019 Apr;8(2):181-183. doi: 10.21037/hbsn.2018.12.11. No abstract available.

5.

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.

Wijarnpreecha K, Panjawatanan P, Aby E, Ahmed A, Kim D.

Maturitas. 2019 Jun;124:48-54. doi: 10.1016/j.maturitas.2019.03.016. Epub 2019 Mar 25. Review.

PMID:
31097179
6.

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.

Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A.

Liver Int. 2019 May 13. doi: 10.1111/liv.14135. [Epub ahead of print]

PMID:
31081997
7.

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017.

Kim D, Li AA, Cholankeril G, Kim SH, Ingelsson E, Knowles JW, Harrington RA, Ahmed A.

Diabetologia. 2019 Jul;62(7):1185-1194. doi: 10.1007/s00125-019-4870-9. Epub 2019 Apr 22.

PMID:
31011776
8.

Genetic Factors Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups.

Yoo ER, Ahmed A, Kim D.

Clin Gastroenterol Hepatol. 2019 Apr 19. pii: S1542-3565(19)30424-0. doi: 10.1016/j.cgh.2019.04.034. [Epub ahead of print] No abstract available.

PMID:
31009797
9.

Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Cholankeril G, Tighe SP, Kim W, Harrison SA, Ahmed A.

Liver Int. 2019 Mar 29. doi: 10.1111/liv.14110. [Epub ahead of print]

PMID:
30924602
10.

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management.

Fernandes CT, Iqbal U, Tighe SP, Ahmed A.

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619836138. doi: 10.1177/2324709619836138.

11.

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.

Iqbal U, Perumpail BJ, Akhtar D, Kim D, Ahmed A.

Medicines (Basel). 2019 Mar 18;6(1). pii: E41. doi: 10.3390/medicines6010041. Review.

12.

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.

Wijarnpreecha K, Kim D, Raymond P, Scribani M, Ahmed A.

Eur J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1097/MEG.0000000000001397. [Epub ahead of print]

PMID:
30888971
13.

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2019 Feb 25;7(1). pii: E27. doi: 10.3390/diseases7010027. Review.

14.

A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPĪ± expression.

Myers LM, Tal MC, Torrez Dulgeroff LB, Carmody AB, Messer RJ, Gulati G, Yiu YY, Staron MM, Angel CL, Sinha R, Markovic M, Pham EA, Fram B, Ahmed A, Newman AM, Glenn JS, Davis MM, Kaech SM, Weissman IL, Hasenkrug KJ.

Nat Commun. 2019 Feb 15;10(1):794. doi: 10.1038/s41467-019-08637-9.

15.

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.

Kim D, Kim W, Adejumo AC, Cholankeril G, Tighe SP, Wong RJ, Gonzalez SA, Harrison SA, Younossi ZM, Ahmed A.

Hepatol Int. 2019 Mar;13(2):205-213. doi: 10.1007/s12072-018-09926-z. Epub 2019 Jan 29.

PMID:
30694445
16.

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft.

Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, Kim D, Ahmed A.

J Clin Transl Hepatol. 2018 Dec 28;6(4):420-424. doi: 10.14218/JCTH.2018.00010. Epub 2018 Jul 28. Review.

17.

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis.

Iqbal U, Dennis BB, Li AA, Cholankeril G, Kim D, Khan MA, Ahmed A.

Hepatol Int. 2019 Jan;13(1):84-90. doi: 10.1007/s12072-018-9918-2. Epub 2018 Dec 12.

PMID:
30539518
18.

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.

Younossi ZM, Stepanova M, Ong J, Yilmaz Y, Duseja A, Eguchi Y, El Kassas M, Castellanos-Fernandez M, George J, Jacobson IM, Bugianesi E, Wong VW, Arrese M, de Ledinghen V, Romero-Gomez M, Mendez-Sanchez N, Ahmed A, Wong R, Papatheodoridis G, Serfaty L, Younossi I, Nader F, Ziayee M, Afendy A; Global NASH Council.

Clin Gastroenterol Hepatol. 2018 Nov 23. pii: S1542-3565(18)31276-X. doi: 10.1016/j.cgh.2018.11.033. [Epub ahead of print]

PMID:
30476585
19.

Iron Deficiency Anaemia In Pakistan: Celiac Disease An Underlying Cause.

Khatoon S, Ahmed A, Yousaf S.

J Ayub Med Coll Abbottabad. 2018 Jul-Sep;30(3):372-376.

20.

Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States.

Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, Cholankeril G, Hameed B, Ahmed A.

Clin Gastroenterol Hepatol. 2018 Nov 17. pii: S1542-3565(18)31267-9. doi: 10.1016/j.cgh.2018.11.024. [Epub ahead of print]

PMID:
30458247

Supplemental Content

Loading ...
Support Center